Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5322 ARTÍCULOS , VIENDO DEL 4936 AL 4950

Review on the interactions between dopamine metabolites and α-Synuclein in causing Parkinson's disease

Sivakumar P, Nagashanmugam KB, Priyatharshni S, Lavanya R, Prabhu N, Ponnusamy S.

Neurochem Int. 2023 Jan;162:105461. doi: 10.1016/j.neuint.2022.105461. Epub 2022 Nov 30.

Toll-like receptors and NLRP3 inflammasome-dependent pathways in Parkinson's disease: mechanisms and therapeutic implications

Soraci L, Gambuzza ME, Biscetti L, Laganà P, Lo Russo C, Buda A, Barresi G, Corsonello A, Lattanzio F, Lorello G, Filippelli G, Marino S.

J Neurol. 2023 Mar;270(3):1346-1360. doi: 10.1007/s00415-022-11491-3. Epub 2022 Dec 3.

Results of a Randomized Clinical Trial of Speech After Early Neurostimulation in Parkinson's Disease

Pinto S, Nebel A, Rau J, Espesser R, Maillochon P, Niebuhr O, Krack P, Witjas T, Ghio A, Cuartero MC, Timmermann L, Schnitzler A, Hesekamp H, Meier N, Müllner J, Hälbig TD, Möller B, Paschen S, Paschen L, Volkmann J, Barbe MT, Fink GR, Becker J, Reker P, Kühn AA, Schneider GH, Fraix V, Seigneuret E, Kistner A, Rascol O, Brefel-Courbon C, Ory-Magne F, Hartmann CJ, Wojtecki L, Fradet A, Maltête D, Damier P, Le Dily S, Sixel-Döring F, Benecke P, Weiss D, Wächter T, Pinsker MO, Régis J, Thobois S, Polo G, Houeto JL, Hartmann A, Knudsen K, Vidailhet M, Schüpbach M, Deuschl G; EARLYSTIM Study Group.

Mov Disord. 2023 Feb;38(2):212-222. doi: 10.1002/mds.29282. Epub 2022 Dec 3.

The factor structure of extrapyramidal symptoms evaluated using the Drug-Induced Extrapyramidal Symptoms Scale in patients with schizophrenia: Results from the 2016 REAP AP-4 study

Kubota C, Inada T, Lin SK, Avasthi A, Chee KY, Tanra AJ, Yang SY, Chen LY, Chong MY, Tripathi A, Kallivayalil RA, Grover S, Park SC, Kato TA, Xiang YT, Sim K, Maramis MM, Noor IM, Tan CH, Sartorius N, Shinfuku N.

Hum Psychopharmacol. 2023 Mar;38(2):e2861. doi: 10.1002/hup.2861. Epub 2022 Dec 3.

Physical-mental multimorbidity in a large primary health care population in Stockholm County, Sweden

Taloyan M, Alinaghizadeh H, Wettermark B, Jan Hasselström JH, Bertilson BC.

Asian J Psychiatr. 2023 Jan;79:103354. doi: 10.1016/j.ajp.2022.103354. Epub 2022 Nov 29.

Constipation in Parkinson's Disease: A Systematic Review and Meta-Analysis

Yao L, Liang W, Chen J, Wang Q, Huang X.

Eur Neurol. 2023;86(1):34-44. doi: 10.1159/000527513. Epub 2022 Dec 5.

Alternative role of glucagon-like Peptide-1 receptor agonists in neurodegenerative diseases

Chen SD, Chuang YC, Lin TK, Yang JL.

Eur J Pharmacol. 2023 Jan 5;938:175439. doi: 10.1016/j.ejphar.2022.175439. Epub 2022 Dec 2.

The complex role of inflammation and gliotransmitters in Parkinson's disease

Gopinath A, Mackie PM, Phan LT, Tansey MG, Khoshbouei H.

Neurobiol Dis. 2023 Jan;176:105940. doi: 10.1016/j.nbd.2022.105940. Epub 2022 Dec 5.

Do dance style and intervention duration matter in improving balance among people with Parkinson's disease? A systematic review with meta-analysis

Simpkins C, Yang F.

Parkinsonism Relat Disord. 2023 Jan;106:105231. doi: 10.1016/j.parkreldis.2022.105231. Epub 2022 Nov 29.

Adaptive deep brain stimulation for Parkinson's disease: looking back at the past decade on motor outcomes

An Q, Yin Z, Ma R, Fan H, Xu Y, Gan Y, Gao Y, Meng F, Yang A, Jiang Y, Zhu G, Zhang J.

J Neurol. 2023 Mar;270(3):1371-1387. doi: 10.1007/s00415-022-11495-z. Epub 2022 Dec 6.

Determination of the motor status of patients with advanced Parkinson's disease under levodopa-carbidopa intestinal gel using a machine learning model

Efthymiopoulou E, Antonoglou A, Loupo B, Bougea A.

Acta Neurol Belg. 2023 Apr;123(2):565-570. doi: 10.1007/s13760-022-02156-z. Epub 2022 Dec 6.

An intensive neurorehabilitation programme with sEMG biofeedback to improve swallowing in idiopathic Parkinson's disease (IPD): A feasibility study

Battel I, Walshe M.

Int J Lang Commun Disord. 2023 May;58(3):813-825. doi: 10.1111/1460-6984.12824. Epub 2022 Dec 8.

[Parkinson's disease]

Warnecke T, Lummer C, Rey JW, Claus I, Lüttje D.

Inn Med (Heidelb). 2023 Feb;64(2):131-138. doi: 10.1007/s00108-022-01444-3. Epub 2022 Dec 8.

Effects of Palliative Care for Progressive Neurologic Diseases: A Systematic Review and Meta-Analysis

Chan LML, Yan OY, Lee JJJ, Lam WWT, Lin CC, Auyeung M, Bloem BR, Kwok JYY.

J Am Med Dir Assoc. 2023 Feb;24(2):171-184. doi: 10.1016/j.jamda.2022.11.001. Epub 2022 Dec 5.

Proteostasis in Parkinson's disease: Recent development and possible implication in diagnosis and therapeutics

Kulkarni A, Preeti K, Tryphena KP, Srivastava S, Singh SB, Khatri DK.

Ageing Res Rev. 2023 Feb;84:101816. doi: 10.1016/j.arr.2022.101816. Epub 2022 Dec 6.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias